[EN]Artificial intelligence (AI) has emerged as a transformative tool in the pharmaceutical industry, revolutionizing the traditional drug discovery and development process. Through advanced generative techniques, such as Generative Adversarial Networks (GANs) and Variational Autoencoders (VAEs), the exploration and design of novel and viable therapeutic molecules has been enhanced. Additionally, AI facilitates the optimization of these molecules by guaranteeing desirable properties and accelerates the identification of therapeutic targets through deep analysis of biomedical and genomic data sets. One of the most significant advances has been drug repurposing, where AI unlocks the hidden potential of known drugs for new therapeutic indications..
